Published in Clin Transl Gastroenterol on October 08, 2015
Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol (2004) 2.86
Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol (2004) 2.65
Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol (2005) 2.36
Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis. Arch Intern Med (2005) 2.35
Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol (2008) 2.28
Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol (2003) 2.21
Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med (2016) 1.82
Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol (2009) 1.76
Bilateral temporomandibular joint dislocation after PEG tube placement. Gastrointest Endosc (2004) 1.70
Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc (2010) 1.69
Peptic ulcer/stricture after gastric bypass: a comparison of technique and acid suppression variables. Obes Surg (2002) 1.67
Proton pump inhibitor therapy use does not predispose to small intestinal bacterial overgrowth. Am J Gastroenterol (2012) 1.60
Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium. Am J Gastroenterol (2002) 1.56
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroenterol (2004) 1.52
Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress. Am J Gastroenterol (2003) 1.50
Bladder cancer presenting as lower-GI bleeding. Dig Dis Sci (2008) 1.47
Clinical predictors of Barrett's esophagus length. Gastrointest Endosc (2005) 1.45
Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil (2011) 1.32
The effect of life stress on symptoms of heartburn. Psychosom Med (2004) 1.28
Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y) (2007) 1.27
Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am (2003) 1.26
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22
The diagnosis of gastroesophageal reflux disease. Am J Med (2010) 1.17
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Chronic intestinal pseudo-obstruction. Nutr Clin Pract (2013) 1.14
Laparoscopic resection of a small bowel lipoma with incidental intussusception. JSLS (2011) 1.12
Increased expression and secretion of interleukin-6 in patients with Barrett's esophagus. Clin Cancer Res (2004) 1.10
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials (2012) 1.10
Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology (2007) 1.07
Pharmacological management of GERD: where does it stand now? Trends Pharmacol Sci (2011) 1.06
Chronic pancreatitis and its effect on employment and health care experience: results of a prospective American multicenter study. Pancreas (2010) 1.05
Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? Clin Gastroenterol Hepatol (2004) 1.05
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol (2010) 1.04
Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am (2004) 1.04
Relationships between sleep quality and pH monitoring findings in persons with gastroesophageal reflux disease. J Clin Sleep Med (2007) 1.03
The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci (2013) 1.00
Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders? Dig Dis Sci (2008) 0.99
A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2008) 0.99
An algorithm for diagnosis and treatment of refractory GERD. Best Pract Res Clin Gastroenterol (2010) 0.98
Treatment of patients with diabetic gastroparesis. Gastroenterol Hepatol (N Y) (2010) 0.95
The pathophysiology of non-cardiac chest pain. J Gastroenterol Hepatol (2005) 0.95
Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid. Am J Gastroenterol (2006) 0.95
The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol (2008) 0.93
Nonmedical therapeutic strategies for nonerosive reflux disease. J Clin Gastroenterol (2014) 0.93
Gastroesophageal reflux disease and sleep disturbances. J Gastroenterol (2012) 0.91
Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups. Am J Gastroenterol (2006) 0.91
Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol (2011) 0.90
Multiple myeloma presenting with a colonic obstruction and bony lesions: a clinical dilemma. J Clin Oncol (2008) 0.90
Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Dig Dis Sci (2003) 0.89
Mixed acinar-endocrine carcinoma arising in the ampulla of Vater. Hum Pathol (2002) 0.89
Dexlansoprazole MR: a review. Ann Med (2011) 0.88
The role of proton pump inhibitors in gastro-oesophageal reflux disease. Drugs (2004) 0.88
Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) (2007) 0.87
Gastroesophageal reflux disease: presentation and assessment of a common, challenging disorder. Clin Cornerstone (2003) 0.86
Conscious awakenings are commonly associated with Acid reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol (2010) 0.85
Impact of anal incontinence on psychosocial function and health-related quality of life. Dig Dis Sci (2007) 0.84
Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84
Extraesophageal and atypical manifestations of GERD. J Gastroenterol Hepatol (2004) 0.84
Treatment of esophageal motility disorders based on the chicago classification. Curr Treat Options Gastroenterol (2014) 0.84
Power spectral analysis of the sleep electroencephalogram in heartburn patients with or without gastroesophageal reflux disease: a feasibility study. J Clin Gastroenterol (2010) 0.83
Attitudes and referral patterns of primary care physicians when evaluating subjects with noncardiac chest pain--a national survey. Dig Dis Sci (2005) 0.83
Pathogenesis of diarrhea in the adult: diagnostic challenges and life-threatening conditions. Eur J Gastroenterol Hepatol (2006) 0.83
The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease. J Clin Gastroenterol (2012) 0.83
Progression or regression of Barrett's esophagus--is it all in the eye of the beholder? Am J Gastroenterol (2003) 0.83
Gastroesophageal reflux disease and irritable bowel syndrome: a common overlap syndrome. Curr Gastroenterol Rep (2006) 0.83
Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol (2009) 0.82
Noncardiac chest pain. Clin Gastroenterol Hepatol (2006) 0.82
Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol (2009) 0.82
Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg (2006) 0.82
Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease. J Psychosom Res (2013) 0.82
Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy. Drugs (2011) 0.81
Ambulatory esophageal pH monitoring: new directions. Dig Dis (2006) 0.81
Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information. Am J Gastroenterol (2009) 0.81
Physicians and patients measure different dimension on assessment for gastroesophageal reflux disease-related symptoms [corrected]. J Neurogastroenterol Motil (2011) 0.81
Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol (2002) 0.81
Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil (2012) 0.80
Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci (2002) 0.80
Gastroesophageal reflux disease and sleep. Gastroenterol Clin North Am (2013) 0.80
Review: treatment of gastroesophageal reflux disease in the elderly. Am J Med (2010) 0.80
Functional heartburn. Curr Treat Options Gastroenterol (2005) 0.79
GERD: are functional heartburn and functional dyspepsia one disorder? Nat Rev Gastroenterol Hepatol (2010) 0.79
New therapies for non-cardiac chest pain. Curr Gastroenterol Rep (2014) 0.79
A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Gastrointest Endosc (2003) 0.79
Gastroparesis: A Review of Current Diagnosis and Treatment Options. J Clin Gastroenterol (2015) 0.78
The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity. Dig Dis Sci (2009) 0.78
Esophageal reflux and motility update: GERD, NERD and spasm. Introduction. J Clin Gastroenterol (2008) 0.78
Irritable bowel syndrome: new recommendations for diagnosis and treatment. Arch Intern Med (2003) 0.78
Functional dyspepsia: Validation and results of a novel survey instrument to evaluate patient knowledge and perceptions. J Clin Gastroenterol (2009) 0.78
Colon cancer presenting as upper-GI bleeding. Gastrointest Endosc (2006) 0.78
Current perspectives on the diagnosis and treatment of functional esophageal disorders. Curr Gastroenterol Rep (2003) 0.78
Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res (2009) 0.78
Impaired sleep quality in Crohn's disease depends on disease activity. Dig Dis Sci (2013) 0.78
Esophageal peristaltic defects in adults with functional dysphagia. Dysphagia (2014) 0.77
An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium. Gastroenterol Hepatol (N Y) (2010) 0.77
Patient knowledge and perspective on irritable bowel syndrome: development of a survey instrument. Dig Dis Sci (2007) 0.77
Esophageal manometry and pH monitoring: gastroenterologists' adherence to published guidelines. J Clin Gastroenterol (2005) 0.77
Assessment of relationship between acid reflux and heartburn using receiver operating characteristic curves. Gastroenterol Clin North Am (2002) 0.77